Top Buy
Wertpapier | Buy | Sell | Buy (1W) ▲ | Sell (1W) | Kurs | Kursziel | Potential |
---|---|---|---|---|---|---|---|
Ipsen S.A. | 1 | 0 | 0 | 0 | 123,00 € | - | - |
UCB S.A. | 1 | 0 | 0 | 0 | 129,75 € | - | - |
Sanofi S.A. | 4 | 1 | 0 | 1 | 90,20 € | 99,50 € | 10,31 % |
Virbac S.A. | 1 | 0 | 0 | 0 | 346,50 € | - | - |
Cerenis Therapeutics Holding S.A. | 1 | 0 | 0 | 0 | 1,18 € | 1,60 € | 35,36 % |
Zoetis Inc. A | 23 | 1 | 0 | 0 | 161,74 € | 200,06 € | 23,69 % |
AstraZeneca plc | 2 | 0 | 0 | 0 | 147,00 € | 165,00 € | 12,24 % |
QIAGEN NV | 8 | 0 | 0 | 0 | 40,47 € | 47,44 € | 17,22 % |
Grifols S.A. | 1 | 0 | 0 | 0 | 9,47 € | - | - |
MorphoSys AG | 7 | 0 | 0 | 0 | 67,70 € | 65,00 € | -3,99 % |
Amgen Inc. | 25 | 0 | 0 | 0 | 282,95 € | 297,31 € | 5,08 % |
Novo Nordisk A/S | 5 | 0 | 0 | 0 | 185,00 € | 170,00 € | -8,11 % |
Pfizer Inc. | 27 | 5 | 0 | 1 | 27,22 € | 40,66 € | 49,40 % |
Eli Lilly Corp. | 49 | 0 | 0 | 0 | 765,40 € | 786,51 € | 2,76 % |
Merck KGaA | 3 | 1 | 0 | 0 | 171,10 € | 146,00 € | -14,67 % |
Perrigo Co. plc | 3 | 0 | 0 | 0 | 24,28 € | 35,99 € | 48,21 % |
Incyte Corp. | 12 | 2 | 0 | 0 | 54,30 € | 78,42 € | 44,42 % |
Nektar Therapeutics | 3 | 1 | 0 | 0 | 1,31 € | 3,70 € | 182,23 % |